NO20062142L - Farmasoytisk doseringsform med forlenget frigjoring - Google Patents

Farmasoytisk doseringsform med forlenget frigjoring

Info

Publication number: NO20062142L
Authority: NO; Norway
Prior art keywords: venlafaxine; dosage forms; release pharmaceutical; pharmaceutical dosage; dosage form
Prior art date: 2003-10-13

Application number

NO20062142A

Other languages

English (en)

Norwegian (no)

Inventor

James Andrew Provost

Nicholas Heaton

Angela Potts

Ian Armstrong

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-13

Filing date

2006-05-12

Publication date

2006-07-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34354596&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20062142(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-05-12 Application filed by Wyeth Corp filed Critical Wyeth Corp

2006-07-06 Publication of NO20062142L publication Critical patent/NO20062142L/no

Links

239000002552 dosage form Substances 0.000 title abstract 5
238000013265 extended release Methods 0.000 title 1
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
229960004688 venlafaxine Drugs 0.000 abstract 2
241000282414 Homo sapiens Species 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
KYYIDSXMWOZKMP-UHFFFAOYSA-N O-desmethylvenlafaxine Chemical compound C1CCCCC1(O)C(CN(C)C)C1=CC=C(O)C=C1 KYYIDSXMWOZKMP-UHFFFAOYSA-N 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20062142A 2003-10-13 2006-05-12 Farmasoytisk doseringsform med forlenget frigjoring NO20062142L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03256438A EP1523979A1 (en)	2003-10-13	2003-10-13	Extended release pharmaceutical dosage form
PCT/EP2004/011339 WO2005039527A2 (en)	2003-10-13	2004-10-11	Extended release pharmaceutical dosage form

Publications (1)

Publication Number	Publication Date
NO20062142L true NO20062142L (no)	2006-07-06

Family

ID=34354596

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20062142A NO20062142L (no)	2003-10-13	2006-05-12	Farmasoytisk doseringsform med forlenget frigjoring

Country Status (14)

Country	Link
US (1)	US20050129762A1 (es)
EP (2)	EP1523979A1 (es)
KR (1)	KR20060108675A (es)
CN (1)	CN1889935A (es)
AR (1)	AR046102A1 (es)
AU (1)	AU2004283436A1 (es)
CA (1)	CA2546199A1 (es)
CO (1)	CO5690532A2 (es)
CR (1)	CR8403A (es)
EC (1)	ECSP066566A (es)
NO (1)	NO20062142L (es)
PE (1)	PE20050439A1 (es)
TW (1)	TW200518788A (es)
WO (1)	WO2005039527A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008525313A (ja) *	2004-12-27	2008-07-17	エーザイ・アール・アンド・ディー・マネジメント株式会社	抗痴呆薬の安定化方法
US20060246003A1 (en) *	2004-12-27	2006-11-02	Eisai Co. Ltd.	Composition containing anti-dementia drug
US20060280789A1 (en) *	2004-12-27	2006-12-14	Eisai Research Institute	Sustained release formulations
US20090208579A1 (en) *	2004-12-27	2009-08-20	Eisai R & D Management Co., Ltd.	Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
WO2008074145A1 (en) *	2006-12-20	2008-06-26	Genpharm Ulc	Pharmaceutical composition comprising a hot-melt granulated lubricant
AU2014201170B2 (en) *	2006-12-20	2015-09-24	Mylan Pharmaceuticals Ulc	Pharmaceutical composition comprising a hot-melt granulated lubricant
US8142803B2 (en)	2007-03-22	2012-03-27	Magceutics, Inc.	Magnesium compositions and uses thereof for neurological disorders
MX2009009939A (es)	2007-03-22	2010-09-24	Magceutics Inc	Composiciones de magnesio y usos de la misma.
EP2448413A4 (en)	2009-07-01	2013-02-13	Magceutics Inc	SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF
WO2018200885A1 (en)	2017-04-26	2018-11-01	Neurocentria, Inc.	Magnesium compositions and methods of use

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE556141A (es) *	1956-03-27
US4535186A (en) *	1983-04-19	1985-08-13	American Home Products Corporation	2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US5530013A (en) *	1994-02-14	1996-06-25	American Home Products Corporation	Venlafaxine in the inducement of cognition enhancement
US5506270A (en) *	1995-01-30	1996-04-09	American Home Products Corporation	Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
US5554383A (en) *	1995-04-06	1996-09-10	Trustees Of Tufts College	Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
US6033686A (en) *	1998-10-30	2000-03-07	Pharma Pass Llc	Controlled release tablet of bupropion hydrochloride
US20030059466A1 (en) *	2001-09-14	2003-03-27	Pawan Seth	Delayed release tablet of venlafaxin
DE10208335A1 (de) *	2002-02-27	2003-09-04	Roehm Gmbh	Arzneiform und Verfahren zu ihrer Herstellung
US20030190352A1 (en) *	2002-03-28	2003-10-09	Synthon Bv	Compositions of venlafaxine base
AU2003219117A1 (en) *	2002-03-28	2003-10-13	Synthon B.V.	Extended release venlafaxine formulations
IL149055A0 (en) *	2002-04-09	2002-11-10	Karma Pharm Ltd	Extended release composition comprising as active compound venlafaxine hydrochloride
EP1558220B1 (en) *	2003-07-24	2010-02-10	Wockhardt Limited	Oral compositions for treatment of diabetes

2003
- 2003-10-13 EP EP03256438A patent/EP1523979A1/en not_active Withdrawn
2004
- 2004-10-11 CN CNA2004800365221A patent/CN1889935A/zh active Pending
- 2004-10-11 EP EP04790255A patent/EP1675575A2/en not_active Withdrawn
- 2004-10-11 KR KR1020067009322A patent/KR20060108675A/ko not_active Withdrawn
- 2004-10-11 CA CA002546199A patent/CA2546199A1/en not_active Abandoned
- 2004-10-11 WO PCT/EP2004/011339 patent/WO2005039527A2/en not_active Ceased
- 2004-10-11 TW TW093130742A patent/TW200518788A/zh unknown
- 2004-10-11 AU AU2004283436A patent/AU2004283436A1/en not_active Abandoned
- 2004-10-12 PE PE2004000984A patent/PE20050439A1/es not_active Application Discontinuation
- 2004-10-12 AR ARP040103689A patent/AR046102A1/es unknown
- 2004-10-13 US US10/964,012 patent/US20050129762A1/en not_active Abandoned
2006
- 2006-05-12 NO NO20062142A patent/NO20062142L/no not_active Application Discontinuation
- 2006-05-12 CR CR8403A patent/CR8403A/es unknown
- 2006-05-12 CO CO06045403A patent/CO5690532A2/es not_active Application Discontinuation
- 2006-05-12 EC EC2006006566A patent/ECSP066566A/es unknown

Also Published As

Publication number	Publication date
CN1889935A (zh)	2007-01-03
ECSP066566A (es)	2006-10-17
WO2005039527A2 (en)	2005-05-06
CA2546199A1 (en)	2005-05-06
TW200518788A (en)	2005-06-16
EP1523979A1 (en)	2005-04-20
PE20050439A1 (es)	2005-08-03
WO2005039527A3 (en)	2006-04-06
AR046102A1 (es)	2005-11-23
EP1675575A2 (en)	2006-07-05
CO5690532A2 (es)	2006-10-31
CR8403A (es)	2006-10-26
AU2004283436A1 (en)	2005-05-06
KR20060108675A (ko)	2006-10-18
US20050129762A1 (en)	2005-06-16

Similar Documents

Publication	Publication Date	Title
CY1121877T1 (el)	2020-10-14	Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη
CY1121350T1 (el)	2020-05-29	Απο του στοματος φαρμακοτεχνικες μορφες αναλογων κυτιδινης και μεθοδοι χρησης αυτων
CY1122575T1 (el)	2020-07-31	Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
EP4681777A3 (en)	2026-04-29	Prodrugs of ketamine, compositions and uses thereof
NO20076508L (no)	2008-03-17	Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
NO20062142L (no)	2006-07-06	Farmasoytisk doseringsform med forlenget frigjoring
CY1110318T1 (el)	2015-01-14	Παραγωγα φαινοξυοξικου οξεος
CY1112115T1 (el)	2015-11-04	Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου
NO20084855L (no)	2009-01-20	Fremgangsmate for fremstilling av poxvirus og poxvirussammensetninger
CY1122416T1 (el)	2021-01-27	Φαρμακα τα οποια περιεχουν κρυσταλλικες τροποποιησεις (1r,2r)-3-(3-δimeθyλamino-1-αιθυλο-2-μεθυλο-προπυλο)-φαινολης
NO20083905L (no)	2008-09-12	Nye pyron-indol derivater og fremgangsmate for deres fremstilling
NO20053972L (no)	2005-08-25	Aminosyre-avledede prodrug av propofol, sammensetninger og anvendelse derav.
ECSP045029A (es)	2004-04-28	Composiciones de valdecoxib de disgregación intraoral
UY27548A1 (es)	2003-06-30	Sales de ácido succínico de 5,7,14-triazatetraciclo (10.3.1.02.11.04,9) exadeca-2 (11),3,5,7,9-pentaeno y composiciones farmacéuticas
NO20082547L (no)	2008-09-22	Orale formuleringer omfattende tigecycline
PT1414816E (pt)	2005-04-29	Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
BRPI0605214A (pt)	2007-10-09	composição farmacêutica orodispersável para administração por via mucosa oral ou sublingual de agomelatina
WO2019194773A3 (en)	2019-12-12	The combination comprising linagliptin and metformin
NO20073760L (no)	2007-07-19	Triazolon-, tetrazolon- og imidazolonderivater for anvendelse som alfa-2C-adrenoreseptorantagonister
NO20071299L (no)	2007-05-29	Vedvarende frigivelse farmasoytisk sammensetning av tolterodine
NO20082690L (no)	2008-08-12	Kjemiske forbindelser
EA200600590A1 (ru)	2006-08-25	Фармацевтические композиции модафинила с модифицированным высвобождением
NO20050861L (no)	2005-02-17	Anvendelse av 1-fenyl-3-dimetylamino-propanforbindelser til terapi av depressive symtpomer
ATE409031T1 (de)	2008-10-15	Tablettenformulierungen von venlafaxin mit verzögerter freisetzung
DK1685096T3 (da)	2007-10-22	Pentafluorsulfanyl-benzoylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som medikamenter indeholdende dem

Legal Events

Date	Code	Title	Description
2007-08-20	FC2A	Withdrawal, rejection or dismissal of laid open patent application